Jushi Holdings Inc. (NEO: JUSH); (OTC: JSHHF) Brings Together
World-Class Financial, Legal and Cannabis
Experience at Precisely the Right Time
Breaking News: Jushi Moves Quickly to Continue its Expansion with Agreements in 3 Significant Markets
The worldwide market for legal cannabis has enjoyed a significant growth phase over the past several years.
In fact, industry analyst Piper Jaffray projects that the global cannabis market could potentially reach $250 billion-per-year in the long term.[i]
This growth has attracted a great deal of investor attention – and there are a number of intriguing investment opportunities that have emerged in its wake.
That’s because Jushi is guided by a team of experienced financial minds who have partnered with cannabis industry veterans to bring a seasoned, well-balanced approach to building shareholder wealth.
Jushi Holdings Inc. (NEO: JUSH); (OTC: JSHHF) has brought together world class financial, legal and creative talent into an impressive team of experts with the goal of becoming a new, vertically-integrated leader in the cannabis industry.
This is a team with a proven track record of success in both financing and investing in cannabis – both domestically and internationally.
With a number of highly-publicized cannabis companies failing to deliver on their promises, Jushi’s leaders saw an opportunity to bring more professional management and accountability to the cannabis space.
Jushi Moves Quickly to Continue its Expansion with Agreements in 3 Significant Markets: California, Virginia and Pennsylvania
1) California – In the summer of 2019, Jushi Inc. (NEO: JUSH); (OTC: JSHHF) has taken a number of significant steps forward to continue its expansion throughout the United States with agreements in three significant markets.
The first of these steps came on July 4 when the company announced an agreement to acquire its first operational adult-use and medical dispensary in San Diego, California. This entry into the California market – larger in size than Canada – provides Jushi with access to the state’s 40 million residents and the longest-running medical cannabis program in the country.
San Diego is the second largest city in California – with a population of 1.4 million – and the city is also a limited license market with a maximum of 36 total retail cannabis licenses available (of which 19 have been issued.)
2) Virginia – Just a few days later – on July 8 – Jushi announced the continuation of its expansion into the Northeastern U.S. by entering into an agreement to acquire Dalitso LLC, a Virginia-based pharmaceutical processor for medical cannabis extracts.
Dalitso is currently one of only five applicants to receive conditional approval for a permit issued by the Virginia Board of Pharmacy to cultivate and process medical cannabis, and to dispense and deliver CBD oil and THC-A oil extracts in Virginia.
Dalitso has received conditional approval to operate within the Virginia Board of Pharmacy-designated Health Service Area II, which includes two of Virginia’s most densely populated counties, Fairfax and Prince William, with 2.4 million people or 28.2% of the state’s total population according to World Population Review.
3) Pennsylvania – On July 11, Jushi announced the closing of its acquisition of four retail medical marijuana dispensary operators in Pennsylvania. Collectively the entities acquired by Jushi hold one Phase I and three Phase II dispensary permits issued by the state of Pennsylvania, allowing for 12 medical marijuana dispensaries in the state.
This investment in Pennsylvania has quickly cemented , Jushi Inc. (NEO: JUSH); (OTC: JSHHF) as a leader in this key northeastern limited license state. The acquisitions include two stores that are already operational with the opportunity for ten more.
That means a potential total of 12 medical dispensaries for Jushi – providing a major retail footprint in a limited license state with favorable medical demographics – in great locations, including the areas of Philadelphia, Scranton and Pittsburgh.
Jushi Holdings Inc. (NEO: JUSH); (OTC: JSHHF) is Built on a Foundation of Five Key Directives
1) Corporate Governance – Jushi was created by industry experts Jim Cacioppo, Erich Mauff and Jon Barack, who saw an opportunity to apply decades of experience to a growing market – and in the process create a superior line of cannabis and hemp products for people around the world. The Company is guided by a seasoned board with experience in building and running successful large-scale businesses.
2) Capital Allocation – Jushi Inc. (NEO: JUSH); (OTC: JSHHF) looks to maximize its value through a balance of organic growth and opportunistic M&A activity. The Company maintains a disciplined four pillar caption allocation methodology:
3) Strategic Deal Structuring – Jushi takes a targeted approach to identifying deals and expanding operations. The Company targets cash generating adult-use markets – such as California or Nevada – and limited license medical markets with a line of sight into adult-use, such as New York or Pennsylvania. This activity is facilitated by:
4) Effective Valuation – Proven valuation experience informs Jushi’s methods and promotes optimal deal terms. The Company’s business development team brings over 100 years of combined experience in M&A, private equity, distressed and special investment situations.
5) Operational Excellence – Jushi Holdings Inc. (NEO: JUSH); (OTC: JSHHF) is working with an award-winning market leader known for cannabis cultivation, processing, retail distribution, compliance and safety in multiple states. The Company recently acquired the trademarks The Clinic™, The Clinic Consulting Services™, The Bank™ and The Lab™ as well as, subject to certain limited exceptions, intellectual property derived from the operations of The Clinic™ Colorado. The Clinic™ Colorado, a Denver-based cannabis company, is known for its intellectual property concerning cannabis cultivation, processing, retail distribution, compliance, and safety in multiple states, and has received more industry awards than any other cannabis company in the US with 32 first place awards. The Clinic™ Colorado has had a track record of success with The BankTM owning intellectual property to cultivation and genetics of over 150 different strains and the Lab’s™ intellectual property consisting of proprietary concentrates and extraction techniques. This sophisticated IP will complement Jushi’s expanding platform.”
Jushi’s subsidiary, Sound Wellness Holdings, Inc, through its full spectrum CBD- hemp derived Mend brand, is working to expand the way cannabis is viewed in the medical community and beyond. Mend is committed to establishing the gold standard for cannabis products including hemp-derived CBD products.
Each Mend product formulation leverages clinical research studies and clinical treatment data gathered from thousands of patients. Products are formulated by board-certified physicians and continuously refined based on new research and results.
Just recently – in May 2019 – Jushi Holdings Inc. announced the opening of the first retail location of its Sound Wellness Holdings, Inc. subsidiary SW Retail Stores, LLC, doing business as Mend, on June 3, 2019.
“The grand opening of the Mend store is a key milestone in the execution of Jushi’s hemp strategy and represents the inception of a high quality, global medical brand,” said Jushi Chairman and CEO Jim Cacioppo.
Mend is a full spectrum CBD store and is located within Dent Tower at 3980 Sheridan Drive, Amherst, NY 14226. Mend products are physician-formulated with phytocannabinoid-rich oil derived from the highest quality hemp plants and promote restful sleep and relaxation and improve general well-being.
The initial Mend product line will consist of: Tinctures, Soft Gel Capsules and Topical Lotions. Later this year, Sound Wellness plans to add a unique Swiss-made, hemp-derived CBD Lozenge to the Mend line.
Jushi Invests Over $5 Million in New York Hemp Project
Earlier in 2019, Jushi Holdings Inc. announced – through its subsidiary Sound Wellness, LLC – that it had received approval of its industrial hemp-CBD processor license application from the State of New York.”
The Company announced plans to invest over $5 million in a high-tech hemp processing operation on the east side of Buffalo, New York. This facility will house a state-of-the-art lab, allowing the Company to create advanced product formulations using CBD distillate, CBD isolate, and water-soluble CBD.
Jushi is Guided By a Team of Proven Leaders with Decades of Business-Building Experience
Jushi Holdings Inc. (NEO: JUSH); (OTC: JSHHF) is led by a team of proven business leaders with significant deal experience. The Company’s seasoned board has decades of experience in building and running successful large-scale businesses.
Jim Cacioppo – Founder, CEO and Chairman of the Board
Jim brings unmatched managerial, start-up, financial and investing experience to his role as Founder, CEO and Chairman of Jushi. Prior to founding Jushi, Jim spent over two decades managing risk, the business and allocating capital in senior management positions at several large hedge funds; two of which were early stage success stories.
Jim is Co-Founder and Managing Partner of One East Partners ($2.3 billion (peak AUM)). Previously, Jim served as President and Co-Portfolio Manager of Sandell Asset Management ($5.0 billion (peak AUM)) and Head of Distressed Debt for Halcyon Management, a global investment firm with over $9 billion in assets. Jim has broad experience in private equity sponsorship particularly in turn-around situations, multiple board level experiences with successful outcomes, and a track record of building early stage companies into large successful businesses as Sponsor, President and CEO. Jim earned his BA from Colgate University and his MBA from Harvard University.
Erich Mauff – Founder, President and Board Member
Erich brings financial and managerial experience to his role as Founder and President of Jushi. Erich spent over 20 years at Deutsche Bank, first heading Capital Markets & Treasury Solutions group, then serving as Managing Director and Vice Chairman of Corporate Finance North America. Erich’s fierce work ethic extends beyond even his executive experience—in 1992, Erich competed in the Olympics for South Africa’s Men’s rowing team. Erich earned his BA from Brown University.
Dr. Lazlo Mechtler, MD – Medical Director, Advisor
Jushi’s Medical Director, Dr. Mechtler is a world-renowned expert and a foremost leading U.S. physician in the study of therapeutic benefits of cannabinoids and related research. Dr. Mechtler is a Professor of Neurology and Oncology and has been practicing for over thirty-four years. He is an international lecturer, has edited five books, and has written over 100 publications. Dr. Mechtler serves as the Medical Director of the DENT Neurologic Institute and DENT Cannabis Clinic based in Buffalo, New York.
Max Cohen – COO, Board Member
Max brings operational experience in the cannabis industry to his role as COO at Jushi. Max serves as Founder and CEO of The Clinic™, a large-scale cannabis retailer. Max is a founding member of the Marijuana Industry Group, and a member of the Board of Directors for the National Cannabis Industry Organization (a national marijuana lobbying and policy organization.) Max was a founding board member pre-IPO of Green Thumb Industries (GTI). Max earned his BS in Business Administration from the University of Montana.
The Bottom Line: Jushi Holdings Inc. (NEO: JUSH); (OTC: JSHHF) Offers Investors Smart Exposure to the Rapidly Growing Legal Cannabis and Hemp Market
Jushi has assembled a collection of world class financial, legal and creative talent – and is quickly emerging as a vertically-integrated leader in the cannabis industry.
There are a wide variety of investment opportunities to consider when looking for exposure to the legal cannabis market. Jushi Holdings Inc. (NEO: JUSH); (OTC: JSHHF) offers investors a smart way to play this rapidly growing market.
Disclaimer: This release/advertorial is a commercial advertisement and is for general information purposes only. This is a Native Advertisement, meaning it is an informational paid marketing piece. MarijuanaStox.com makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Please review all investment decisions with a licensed investment advisor. This Advertorial was paid for by Jushi Holdings Inc. in an effort to enhance public awareness of Jushi Holdings Inc. and its securities. Winning Media has or expects to receive one hundred twenty thousand USD dollars by Jushi Holdings Inc. as a total production budget for this advertising effort. Neither MarijuanaStox.com or Winning Media currently holds the securities of Jushi Holdings Inc. . and does not currently intend to purchase such securities. This Advertorial contains forward-looking statements that involve risks and uncertainties. This Advertorial contains or incorporates by reference forward-looking statements, including certain information with respect to plans and strategies of the featured Company. As such, any statements contained herein or incorporated herein by reference that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believe(s)” “anticipate(s)”, “plan(s)” “expect(s)” “project(s)” “will” “make” “told” and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cau se actual events or actual results of the Company to differ materially from these indicated by such forward-looking statements. Certain statements contained herein constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Such statements include, without limitation, statements regarding business, financing, business trends, future operating revenues and expenses. There can be no assurance that such expectations will prove to be correct. Investors are cautioned that any forward-looking statements made by the Company, or contained in this advertorial are not guarantees of future performance, and that the Issuer’s actual results may differ materially from those set forth in the forward-looking statements. Difference in results can be caused by various factors including, but not limited to, the Company’s ability to be able to successfully complete planned funding agreements, to successfully market its products in competitive industries or to effectively implement its business plan or strategies. To reiterate, information presented in this advertorial contains “forward-looking statements”. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact and may be “forward-looking statements.” Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this advertorial may be identified through the use of words such as “expects,” “will,” “anticipates,” “estimates,” “believes,” “may,” or by statements indicating certain actions “may,” “could,” or “might” occur. More information on the Company may be found at www.sec.gov readers can review all public filings by the Company at the SEC’s EDGAR page. MarijuanaStox.com is not a certified financial analyst or licensed in the securities industry in any manner. The information in this Advertorial is subjective opinion and may not be complete, accurate or current and was paid for, so this could create a conflict of interest.